|
Volumn 9, Issue , 2004, Pages 2605-2617
|
Beta-lactams and their potential use as novel anticancer chemotherapeutics drugs.
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BETA LACTAM;
DNA;
INTERCALATING AGENT;
PRODRUG;
ANIMAL;
APOPTOSIS;
CHEMISTRY;
DNA DAMAGE;
DRUG DESIGN;
HUMAN;
METABOLISM;
NEOPLASM;
RADIOIMMUNOTHERAPY;
REVIEW;
ANIMALS;
ANTICARCINOGENIC AGENTS;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
BETA-LACTAMS;
DNA;
DNA DAMAGE;
DRUG DESIGN;
HUMANS;
INTERCALATING AGENTS;
NEOPLASMS;
PRODRUGS;
RADIOIMMUNOTHERAPY;
|
EID: 31144455736
PISSN: None
EISSN: 10934715
Source Type: Journal
DOI: 10.2741/1420 Document Type: Review |
Times cited : (61)
|
References (91)
|